Nurix Therapeutics fetches $120m

San Francisco-based Nurix Therapeutics Inc, a developer of targeted protein modulation drugs, has secured $120 million in financing.

To read this article, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to read this article and more for free.

Share this